AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic RelationshipsPRNewsWire • 01/29/26
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 01/28/26
Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics MedicinePRNewsWire • 01/28/26
The AbbVie Foundation Is Now Accepting Applications to Participate in the 2026 AbbVie Foundation Health Equity AcceleratorBusiness Wire • 01/27/26
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring IncomeThe Motley Fool • 01/22/26
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVieThe Motley Fool • 01/19/26
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)PRNewsWire • 01/16/26
Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage studyReuters • 01/16/26
AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Wall Street Bulls Look Optimistic About AbbVie (ABBV): Should You Buy?Zacks Investment Research • 01/14/26